Table 3.
Angiogenesis-associated miRNAs in hepatocellular carcinoma
| microRNA | Expression in HCC | Target | Effect on angiogenesis (inhibit/induce) | Model (in vivo, in vitro, human) | Type of cell line | Reference |
|---|---|---|---|---|---|---|
| miR-1301 | down | BCL9 | inhibit | in vitro, in vivo, human | Hep3B, HepG2, SMMC-7721, Huh-7 | Yang et al.147 |
| miR-26b-5p | down | VE-cadherin, snail, MMP2 | inhibit | in vitro, in vivo | Bel7402, SMMC7721, HepG2, PLC, LO2 | Wang et al.148 |
| miR-199a-3p | down | VEGFA, VEGFR2, VEGFR1, HGF, MMP2 | inhibit | in vitro, in vivo | HepG2, SNU449 | Ghosh et al.149 |
| miR-203a | up | HOXD3, VEGFR | inhibit | in vitro, in vivo | SMMC-7721, Hep3B | Ghosh et al.149 |
| miR-144-3p | down | SGK3 | inhibit | in vitro, in vivo, human | QGY-7703, SK-hep1 | Wu et al.150 |
| miR-497 | down | VEGFA, AEG-1 | inhibit | in vitro, human, in vivo | PLC/PRF/5, SMMC-7721, HepG2, Huh7, SK-HEP-1, Hep3B | Yan et al.151 |
| miR-142 | down | TGF-β | inhibit | in vitro, human | HepG-2, SMMC-7721 | Yu et al.152 |
| miR-126 | up | EGFL7 | inhibit | in vitro, in vivo, human | MMC-7721, MHCC-97H, HCCLM3 | Yu et al.152 |
| miR-338-3p | down | MACC1, VEGF, β-catenin | inhibit | in vitro, human | Hep3B, Huh7, HepG2, Bel-7402, HEK293T | Zhang et al.153 |
| miR-638 | down | VEGF | induce | in vitro, in vivo, human | Hep3B, SMMC-7721, HepG2, MHCC-97L, MHCC-97H | Cheng et al.154 |
| miR-126 | down | EGFL7 | inhibit | in vitro, in vivo, human | HepG2, Bet-7402, SMMC-7721 | Gong et al.146 |
| miR-210 | up | FGFRL1 | induce | in vitro, in vivo, human | HL-7702, SMMC-7721 | Yang et al.155 |
| miR-182 | up | RASA1 | induce | in vitro, human | SK-HEP-1, HCC-LM3 | Du et al.156 |
| miR-126 | down | Spred1 | inhibit | in vitro, human | Ji et al.157 | |
| miR-26a | down | HGF | inhibit | in vitro, in vivo, human | HUVECs | Yang et al.158 |
| miR-126-3p | down | LRP6, PIK3R2 | inhibit | in vitro, human | HepG2, SMMC-7721, BEL-7402 | Du et al.159 |
| miR-195 | down | VEGF, VAV2, CDC42 | inhibit | in vitro, in vivo, human | MHCC-97L, Huh-7, QGY-7703, MHCC-97H, SMMC-7721 | Wang et al.160 |
| miR-302a/b/c | down | MACC1 | inhibit | in vitro | cell line missing | Cao et al.161 |
| miR-26a | down | VEGFA | inhibit | in vitro, in vivo, human | HepG2 | Chai et al.162 |
| miR-146a | up | PDGFRA | induce | in vitro, in vivo | HCCLM3 | Zhu et al.141 |
| miR-506 | down | SPHK1 | inhibit | in vitro, human | HepG2 | Lu et al.134 |
| miR-98 and miR-214 | down | VEGF, Ang-1, MMP-2 | inhibit | in vitro | HepG2 | Yahya et al.163 |
| miR-375 | up | PDGFC | inhibit | in vitro, human | Hep3B, HepG2, Huh1, Huh7 | Li et al.164 |
| miR-503 | down | FGF2, VEGFA | inhibit | human, in vitro, in vivo | HepG2, LO2 | Zhou et al.130 |
| miR-29b | down | MMP-2 | inhibit | human, in vitro, in vivo | Fang et al.125 | |
| miR-200b | down | ERG | induce | in vitro, human | Hep3B | Moh-Moh-Aung et al.165 |